161 related articles for article (PubMed ID: 35116329)
41. LncRNA-H19 regulates chemoresistance to carboplatin in epithelial ovarian cancer through microRNA-29b-3p and STAT3.
Tian X; Zuo X; Hou M; Li C; Teng Y
J Cancer; 2021; 12(19):5712-5722. PubMed ID: 34475985
[No Abstract] [Full Text] [Related]
42. Elevated β-catenin activity contributes to carboplatin resistance in A2780cp ovarian cancer cells.
Barghout SH; Zepeda N; Xu Z; Steed H; Lee CH; Fu Y
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):173-8. PubMed ID: 26522223
[TBL] [Abstract][Full Text] [Related]
43. [Lipoxin A4 inhibits the invasion and migration of endometrial stromal cells by down-regulating NF-κB signaling-mediated autophagy].
Li YH; Geng YY; Liu L; Chen CY; Gao Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Aug; 53(8):547-553. PubMed ID: 30138965
[No Abstract] [Full Text] [Related]
44. Long non-coding RNA GClnc1 knockdown suppresses progression of epithelial ovarian cancer by recruiting FOXC2 to disrupt the NOTCH1/NF-κB/Snail pathway.
Wu D; Ke Y; Xiao R; Liu J; Li Q; Wang Y
Exp Cell Res; 2021 Feb; 399(1):112422. PubMed ID: 33338479
[TBL] [Abstract][Full Text] [Related]
45. β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells.
Cianfrocca R; Tocci P; Semprucci E; Spinella F; Di Castro V; Bagnato A; Rosanò L
Life Sci; 2014 Nov; 118(2):179-84. PubMed ID: 24530737
[TBL] [Abstract][Full Text] [Related]
46. Low expression of MYCN promotes cisplatin resistance by suppressing cisplatin-induced apoptosis in epithelial ovarian cancer.
Yu R; Zhang H; Wang R; Xiao L
Oncol Lett; 2022 Dec; 24(6):423. PubMed ID: 36284653
[TBL] [Abstract][Full Text] [Related]
47. The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer.
Helland Ø; Popa M; Bischof K; Gjertsen BT; McCormack E; Bjørge L
PLoS One; 2016; 11(6):e0158208. PubMed ID: 27352023
[TBL] [Abstract][Full Text] [Related]
48. Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer.
Wahba J; Natoli M; Whilding LM; Parente-Pereira AC; Jung Y; Zona S; Lam EW; Smith JR; Maher J; Ghaem-Maghami S
Cancer Immunol Immunother; 2018 Nov; 67(11):1753-1765. PubMed ID: 30167862
[TBL] [Abstract][Full Text] [Related]
49. AEG-1 Contributes to Metastasis in Hypoxia-Related Ovarian Cancer by Modulating the HIF-1alpha/NF-kappaB/VEGF Pathway.
Yu X; Wang Y; Qiu H; Song H; Feng D; Jiang Y; Deng S; Meng H; Geng J
Biomed Res Int; 2018; 2018():3145689. PubMed ID: 29770329
[TBL] [Abstract][Full Text] [Related]
50. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
51. [Role and mechanism of the regulation of nuclear factor-κB by heparin binding-epidermal growth factor-like growth factor in the induction of paclitaxel resistance of ovarian cancer].
Tang XH; Lu MS; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2019 Apr; 54(4):255-261. PubMed ID: 31006192
[No Abstract] [Full Text] [Related]
52. Targeting RPL23 restores chemosensitivity of cisplatin-resistant ovarian carcinoma by inhibiting EMT.
Liu Y; Lai S; He J; Wan J; Fu F; Jinlong Y
Cytotechnology; 2022 Jun; 74(3):421-432. PubMed ID: 35733701
[TBL] [Abstract][Full Text] [Related]
53. Promotive role of recombinant HE4 protein in proliferation and carboplatin resistance in ovarian cancer cells.
Wang H; Zhu L; Gao J; Hu Z; Lin B
Oncol Rep; 2015 Jan; 33(1):403-12. PubMed ID: 25354091
[TBL] [Abstract][Full Text] [Related]
54. Dihydroartemisinin induces autophagy by suppressing NF-κB activation.
Hu W; Chen SS; Zhang JL; Lou XE; Zhou HJ
Cancer Lett; 2014 Feb; 343(2):239-48. PubMed ID: 24099910
[TBL] [Abstract][Full Text] [Related]
55. MicroRNA 1301 inhibits cisplatin resistance in human ovarian cancer cells by regulating EMT and autophagy.
Yu JL; Gao X
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1688-1696. PubMed ID: 32141535
[TBL] [Abstract][Full Text] [Related]
56. Age-related decrease in proteasome expression contributes to defective nuclear factor-kappaB activation during hepatic ischemia/reperfusion.
Huber N; Sakai N; Eismann T; Shin T; Kuboki S; Blanchard J; Schuster R; Edwards MJ; Wong HR; Lentsch AB
Hepatology; 2009 May; 49(5):1718-28. PubMed ID: 19206148
[TBL] [Abstract][Full Text] [Related]
57. Proteasome inhibitors enhance TRAIL-induced apoptosis through the intronic regulation of DR5: involvement of NF-kappa B and reactive oxygen species-mediated p53 activation.
Chen JJ; Chou CW; Chang YF; Chen CC
J Immunol; 2008 Jun; 180(12):8030-9. PubMed ID: 18523266
[TBL] [Abstract][Full Text] [Related]
58. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
[TBL] [Abstract][Full Text] [Related]
59. GADD45B Facilitates Metastasis of Ovarian Cancer Through Epithelial-Mesenchymal Transition.
Gong L; Cai L; Li G; Cai J; Yi X
Onco Targets Ther; 2021; 14():255-269. PubMed ID: 33469306
[TBL] [Abstract][Full Text] [Related]
60. NV-128, a novel isoflavone derivative, induces caspase-independent cell death through the Akt/mammalian target of rapamycin pathway.
Alvero AB; Montagna MK; Chen R; Kim KH; Kyungjin K; Visintin I; Fu HH; Brown D; Mor G
Cancer; 2009 Jul; 115(14):3204-16. PubMed ID: 19472400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
